{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T19:49:44Z","timestamp":1725652184842},"publisher-location":"Berlin, Heidelberg","reference-count":13,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642816871"},{"type":"electronic","value":"9783642816857"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1982]]},"DOI":"10.1007\/978-3-642-81685-7_6","type":"book-chapter","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T09:49:26Z","timestamp":1326707366000},"page":"29-35","source":"Crossref","is-referenced-by-count":0,"title":["An Intensive Chemo- or Chemoimmunotherapy Regimen for Patients with Intermediate and Poor-Prognosis Acute Lymphatic Leukemia and Leukemic Lymphoblastic Lymphosarcoma: Preliminary Results with 14-Month Median Follow-Up"],"prefix":"10.1007","author":[{"given":"J. L.","family":"Misset","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"De Vassal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ribaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Musset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dorval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Machover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jasmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Schwarzenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(77)91994-8","volume":"1","author":"D Belpomme","year":"1977","unstructured":"Belpomme D, Math\u00e9 G, Davies AJS (1977) Clinical significance and prognostic value of the T-B immunological classification of human primary acute lymphoid leukaemias. Lancet 1:555\u2013558.","journal-title":"Lancet"},{"key":"6_CR2","first-page":"799","volume":"74","author":"J Bernard","year":"1966","unstructured":"Bernard J, Boiron M, Jacquillat C, Weil M, Najean Y (1966) Un nouvel agent actif dans le traitement des leuc\u00e9mies aigu\u00ebs: La cytosine arabinoside. Presse Med 74:799\u2013802","journal-title":"PresseMed"},{"key":"6_CR3","first-page":"299","volume-title":"Human lymphocyte differntiation: Its application to cancer","author":"I Florentin","year":"1978","unstructured":"Florentin I, Kiger N, Bruley-Rosset M, Schulz J, Math\u00e9 G (1978) Effect of seven immunomodulators on different types of immune responses in mice. In: Serrou B, Rosenfeld C (eds) Human lymphocyte differntiation: Its application to cancer. Elsevier\/North-Holland, Biomedical Press, Amsterdam, pp 299\u2013304"},{"key":"6_CR4","first-page":"II","volume-title":"Cancer chemo-and immunopharmacology","author":"I Florentin","year":"1980","unstructured":"Florentin I, Schulz J, Bruley-Rosset M, Kiger N, Math\u00e9 G (1980) In vivo immunomo- dulating properties of two synthetic agents: Azimexon and tuftsin. In: Math\u00e9 G, Muggia F (eds) Cancer chemo- and immunopharmacology. II. Immunopharmacology, relations and general problems. Springer, Berlin Heidelberg New York"},{"key":"6_CR5","first-page":"1980","volume-title":"Second International Conference: Immunotherapy of cancer, present status of trials in man","author":"A Goutner","year":"1980","unstructured":"Goutner A, Schwarzenberg L, Math\u00e9 G (1980) Phase I study of Azimexon in immunodepressed cancer patients. In: Second International Conference: Immunotherapy of cancer, present status of trials in man, Bethesda, xx April 1980"},{"key":"6_CR6","first-page":"402","volume":"71","author":"G Math\u00e9","year":"1963","unstructured":"Math\u00e9 G, Schweisguth O, Brule G, Schneider M, Amiel JL, Schwarzenberg L, Cattan A (1963) Essai de traitement par la cyclophosphamide de la leuc\u00e9mie lymphoblastique aigu\u00eb et du lymphoblastosarcome. Presse Med 71:402\u2013404","journal-title":"Presse Med"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/978-3-662-35334-9","volume-title":"Advancesin the treatment of acute (blastic) leukemias","author":"G Math\u00e9","year":"1970","unstructured":"Math\u00e9 G, Amiel JL, Hayat M et al. (1970) Adriamycin in the treatment of acute leukemias. In: Math\u00e9 G (ed) Advances in the treatment of acute (blastic) leukemias. Springer, Berlin Heidelberg New York, pp 168\u2013172"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00205298","volume":"1","author":"G Math\u00e9","year":"1976","unstructured":"Math\u00e9 G, de Vassal F, Delgado M et al. (1976) 1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy. Cancer Immunol Immunother 1:77\u201386","journal-title":"Cancer Immunol Immunother"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/mpo.2950040105","volume":"4","author":"G Math\u00e9","year":"1978","unstructured":"Math\u00e9 G, de Vassal F, Schwarzenberg L et al. (1978) Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: Distinction of two groups of patients according to predictable prognosis. Med Pediatr Oncol 4:17\u201327","journal-title":"Med Pediatr Oncol"},{"key":"6_CR10","first-page":"805","volume":"62","author":"G Math\u00e9","year":"1978","unstructured":"Math\u00e9 G, Misset JL, de Vassal.F et al. (1978) Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma and Hodgkin\u2019s disease: Absence of crossresistance with vincristine. Cancer Treat Rep 62:805\u2013809","journal-title":"Cancer Treat Rep"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/978-3-642-81246-0","volume-title":"Lymphoid neoplasias II: Clinical and therapeutic aspects","author":"G Math\u00e9","year":"1978","unstructured":"Math\u00e9 G, Misset JL, Gil-Delgado M, Delgado M, de Vassal F (1978) Leukemic (or stage V) lymphosarcoma. In: Math\u00e9 G, Seligmann M, Tubiana M (eds) Lymphoid neoplasias II: Clinical and therapeutic aspects. Springer, Berlin Heidelberg New York, pp 88\u2013107"},{"key":"6_CR12","unstructured":"Misset JL, de Vassal F, Jasmin C, Math\u00e9 G (to be published) Neuroprophylaxis in acute lymphoblastic leukemia. Correlation of neurological risk and efficacy of prevention with other prognostic factors. Eur J Cancer"},{"key":"6_CR13","first-page":"104","volume":"20","author":"G Schaison","year":"1979","unstructured":"Schaison G, Harousseau JL, Jacquillat C, Weil M, Bernard J (1979) Phase I treatment protocol for children with increased risk acute lymphocytic leukemia (IRALL). Proc Am Assoc Cancer Res 20:104","journal-title":"Proc Am Assoc Cancer Res"}],"container-title":["Recent Results in Cancer Research","Adjuvant Therapies of Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-81685-7_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T15:36:56Z","timestamp":1538840216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-81685-7_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"ISBN":["9783642816871","9783642816857"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-81685-7_6","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1982]]}}}